Bristol Myers to Deploy Anthropic's Claude AI Model to Speed up Drug Discovery

Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery - Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb expands AI efforts through Anthropic and Tempus partnerships as shares edge higher Wednesday.

Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery

Bristol Myers Squibb said on Wednesday it is partnering with Anthropic to make ​its Claude AI model available to ‌over 30,000 employees in an effort to accelerate the discovery, development and delivery of new medicines.

Bristol Myers deepens AI investment with Anthropic deal

The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many day-to-day activities.

BMS and Anthropic collaborate for Claude implementation

Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations.

Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations

Anthropic signs enterprise AI deal with Bristol Myers Squibb

Global biopharma company Bristol Myers Squibb announced a strategic agreement with AI safety and research company Anthropic to deploy Claude throughout its research, manufacturing, corporate, clinical development and commercial functions.